Inhibition of neoplastic cell growth by quiescent cells is mediated by serum concentration and cAMP phosphodiesterase inhibitors.
D015087:2',3'-Cyclic-Nucleotide Phosphodiesterases / Q000037:antagonists & inhibitors*; D012368:4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone / Q000494:pharmacology; D000818:Animals; D001769:Blood; D002273:Carcinogens / Q000494:pharmacology; D002450:Cell Communication; D002453:Cell Cycle; D002455:Cell Division / Q000187:drug effects*; D002478:Cells, Cultured; D000242:Cyclic AMP / Q000378:metabolism; D006152:Cyclic GMP / Q000378:metabolism; D004247:DNA / Q000096:biosynthesis; D005347:Fibroblasts / Q000378:metabolism; D051379:Mice; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000473:pathology*; D010726:Phosphodiesterase Inhibitors; D010727:Phosphoric Diester Hydrolases; D014970:Xanthines / Q000494:pharmacology
D002273:Carcinogens; D010726:Phosphodiesterase Inhibitors; D014970:Xanthines; C008514:methylxanthine; D012368:4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; D004247:DNA; D000242:Cyclic AMP; D015087:2',3'-Cyclic-Nucleotide Phosphodiesterases; D010727:Phosphoric Diester Hydrolases; D006152:Cyclic GMP